Today's News | Note: News feeds may no longer be available for the articles on this page.

J&J Readies List of Recession Buyouts, Weldon Says 5:29 AM 1/21/2009
Bloomberg - USA
Johnson & Johnson's CEO has a list of pharmaceutical takeover targets and will take a look at deals involving big drugmakers that may be under pressure. ...

Children’s Staph Infections Increasingly Resistant to Drugs 12:47 PM 1/20/2009
New York Times - United States
Children are getting staph infections that don’t respond to common antibiotics. Ear, nose, and throat infections resistant to standard drugs increased from 11.8 to 28.1 percent over a six-year period. ...

Analyst gives health care top sector rating 10:58 AM 1/20/2009
Forbes - NY,USA
A JPMorgan analyst said that health care is currently the most attractive sector. Stocks in health care could make an average gain of 25 percent in 2009. ...

GeoPharma settles allergy drug suit 10:18 AM 1/20/2009
Bizjournals.com - Charlotte,NC,USA
GeoPharma Inc said it would be able to launch a generic of Clarinex after settling legal action with Schering Corp, Sepracor Inc, and the University of Massachusetts. ...

Abraxis BioScience to spin off unit 7:58 AM 1/20/2009
Reuters - USA
Abraxis BioScience Inc will spin off Abraxis Health Inc focused on biomarkers and personalized medicine. Abraxis BioScience continues developing Abraxane. ...

Teva and Lonza link to tap biosimilar drugs market 5:49 AM 1/20/2009
Reuters - USA
Teva Pharmaceutical Industries is joining forces with Lonza to look for ways to make biosimilar drugs. Perhaps they'll help the US FDA and Congress develop the regulatory pathway to approve these complex molecules. ...

Plants engineered to make better drugs 6:27 AM 1/19/2009
Boston Globe - United States
Genetically reprogramming plant-life to produce compounds that may become drugs to treat cancer or other diseases. ...

Denmark's Lundbeck interested in Elan - report 8:39 AM 1/18/2009
Reuters - USA
Danish pharmaceutical group Lundbeck may be interested in acquiring Elan which hired Citigroup to conduct a strategic review that could lead to a sale or merger of the company. ...

Pfizer’s Bone-Drug Fablyn Fails to Win US Approval 8:58 AM 1/17/2009
Bloomberg - USA
Pfizer Inc failed to win US FDA approval to sell its Fablyn treatment for women with weak bones. The drug may be linked to an increase in deaths. ...

Pfizer to Cut Up to 2400 Jobs 12:06 PM 1/16/2009
Wall Street Journal - USA
Pfizer Inc plans to lay off up to 2,400 sales staff. That's a third of its marketing work force. ...

AstraZeneca Drug Raises Diabetes Risk, Doctor Says 5:56 AM 1/16/2009
Bloomberg - USA
AstraZeneca faces about 9,000 lawsuits in the US claiming Seroquel causes diabetes and other health problems. Seroquel is the company’s second-biggest seller. The first case has come to trial. ...

Osiris gives details on stem cell drug application 12:09 PM 1/15/2009
Forbes - NY,USA
Osiris Therapeutics Inc reached agreement with the US FDA on the details of its application for Prochymal intended to treat Graft vs. host disease. Appears to be the first stem cell product candidate submitted for FDA approval. ...

FDA approves fibromyalgia drug - developers say 6:18 AM 1/15/2009
Reuters - USA
Forest Laboratories Inc and Cypress Bioscience Inc said that the US FDA approved Savella for the management of fibromyalgia. ...

US seeks details of supply chains for foreign drugs 6:16 PM 1/14/2009
Reuters - USA
The US FDA would like details about drug manufacturer's supply chains to protect patients from fake or tainted medicines from overseas. ...

Newer schizophrenia drugs cause heart risks 4:02 PM 1/14/2009
Reuters - USA
The new "atypical" drugs used to treat schizophrenia and other mental disorders may carry a greater risk of a fatal heart attack than older medicines. ...

<- Day Earlier | Today's News